Expansion of effector T cells associated with decreased PD-1 expression in patients with indolent B cell lymphomas and chronic lymphocytic leukemia

References

• Caligaris-Cappio F, Hamblin TJ. B-cell chronic lymphocytic leukemia: a bird of a different feather. J Clin Oncol 1999;17:399–408.
   PubMed Web of Science ®Google Scholar
• Hamblin AD, Hamblin TJ. The immunodeficiency of chronic lymphocytic leukaemia. Br Med Bull 2008;87:49–62.
   PubMed Web of Science ®Google Scholar
• Dunn GP, Bruce AT, Ikeda H, . Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002;3:991–998.
   PubMed Web of Science ®Google Scholar
• Serrano D, Monteiro J, Allen SL, . Clonal expansion within the CD4+ CD57+ and CD8+ CD57+ T cell subsets in chronic lymphocytic leukemia. J Immunol 1997;158:1482–1489.
   PubMed Web of Science ®Google Scholar
• Porakishvili N, Roschupkina T, Kalber T, . Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL). Clin Exp Immunol 2001;126:29–36.
   PubMed Web of Science ®Google Scholar
• Van den Hove LE, Vandenberghe P, Van Gool SW, . Peripheral blood lymphocyte subset shifts in patients with untreated hematological tumors: evidence for systemic activation of the T cell compartment. Leuk Res 1998;22:175–184.
   PubMed Web of Science ®Google Scholar
• Goolsby CL, Kuchnio M, Finn WG, . Expansions of clonal and oligoclonal T cells in B-cell chronic lymphocytic leukemia are primarily restricted to the CD3(+)CD8(+) T-cell population. Cytometry 2000;42:188–195.
   PubMedGoogle Scholar
• Briggs PG, Kraft N, Atkins RC. T cells and CD45R expression in B-chronic lymphocytic leukemia. Leuk Res 1990;14:155–159.
   PubMed Web of Science ®Google Scholar
• Rezvany MR, Jeddi-Tehrani M, Osterborg A, . Oligoclonal TCRBV gene usage in B-cell chronic lymphocytic leukemia: major perturbations are preferentially seen within the CD4 T-cell subset. Blood 1999;94:1063–1069.
   PubMed Web of Science ®Google Scholar
• Farace F, Orlanducci F, Dietrich PY, . T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions. J Immunol 1994;153:4281–4290.
   PubMed Web of Science ®Google Scholar
• Buhmann R, Nolte A, Westhaus D, . CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells. Blood 1999;93:1992–2002.
   PubMed Web of Science ®Google Scholar
• Krackhardt AM, Harig S, Witzens M, . T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy. Blood 2002;100:167–173.
   PubMed Web of Science ®Google Scholar
• Beyer M, Kochanek M, Darabi K, . Reduced frequencies and suppressive function of CD4+ CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine. Blood 2005;106:2018–2025.
   PubMed Web of Science ®Google Scholar
• Jak M, Mous R, Remmerswaal EB, . Enhanced formation and survival of CD4+ CD25hi Foxp3+ T-cells in chronic lymphocytic leukemia. Leuk Lymphoma 2009;50:788–801.
   PubMed Web of Science ®Google Scholar
• Hamann D, Baars PA, Rep MH, . Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 1997;186:1407–1418.
   PubMed Web of Science ®Google Scholar
• Mackus WJ, Frakking FN, Grummels A, . Expansion of CMV-specific CD8+ CD45RA+. Blood 2003;102:1057–1063.
   PubMed Web of Science ®Google Scholar
• Gamadia LE, Rentenaar RJ, Baars PA, . Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers. Blood 2001;98:754–761.
   PubMed Web of Science ®Google Scholar
• Appay V, Zaunders JJ, Papagno L, . Characterization of CD4(+) CTLs ex vivo. J Immunol 2002;168:5954–5958.
   PubMed Web of Science ®Google Scholar
• van Leeuwen EM, Remmerswaal EB, Vossen MT, . Emergence of a CD4+ CD282 granzyme B +, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J Immunol 2004;173:1834–1841.
   PubMed Web of Science ®Google Scholar
• Pourgheysari B, Bruton R, Parry H, . Levels of cytomegalovirus-specific CD4 + T cells are markedly expanded in patients with B-cell chronic lymphocytic leukaemia and determine the total CD4 + T cell repertoire. Blood 2010;116:2968–2974.
   PubMed Web of Science ®Google Scholar
• Boom R, Sol C, Weel J, . A highly sensitive assay for detection and quantitation of human cytomegalovirus DNA in serum and plasma by PCR and electrochemiluminescence. J Clin Microbiol 1999;37: 1489–1497.
   PubMed Web of Science ®Google Scholar
• Zajac AJ, Blattman JN, Murali-Krishna K, . Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 1998;188:2205–2213.
   PubMed Web of Science ®Google Scholar
• Lang KS, Moris A, Gouttefangeas C, . High frequency of human cytomegalovirus (HCMV)-specific CD8 + T cells detected in a healthy CMV-seropositive donor. Cell Mol Life Sci 2002;59:1076–1080.
   PubMed Web of Science ®Google Scholar
• Barber DL, Wherry EJ, Masopust D, . Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006;439:682–687.
   PubMed Web of Science ®Google Scholar
• Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol 2002;2:116–126.
   PubMed Web of Science ®Google Scholar
• Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 2004;4:336–347.
   PubMed Web of Science ®Google Scholar
• Xerri L, Chetaille B, Seriari N, . Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia. Hum Pathol 2008;39:1050–1058.
   PubMed Web of Science ®Google Scholar
• Gorgun G, Holderried TA, Zahrieh D, . Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells. J Clin Invest 2005;115:1797–1805.
   PubMed Web of Science ®Google Scholar
• Ramsay AG, Johnson AJ, Lee AM, . Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. J Clin Invest 2008;118:2427–2437.
   PubMed Web of Science ®Google Scholar
• Ramsay AG, Clear AJ, Kelly G, . Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy. Blood 2009;114:4713–4720.
   PubMed Web of Science ®Google Scholar
• Christopoulos P, Pfeifer D, Bartholome K, . Definition and characterization of the systemic T-cell dysregulation in untreated indolent B-cell lymphoma and very early CLL. Blood 2011;117:3836–3846.
   PubMed Web of Science ®Google Scholar
• Oestreich KJ, Yoon H, Ahmed R, . NFATc1 regulates PD-1 expression upon T cell activation. J Immunol 2008;181:4832–4839.
   PubMed Web of Science ®Google Scholar
• Wong RM, Smith KA, Tam VL, . TLR-9 signaling and TCR stimulation co-regulate CD8(+) T cell-associated PD-1 expression. Immunol Lett 2009;127:60–67.
   PubMed Web of Science ®Google Scholar
• Kinter AL, Godbout EJ, McNally JP, . The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. J Immunol 2008;181:6738–6746.
   PubMed Web of Science ®Google Scholar
• Kater AP, Remmerswaal EB, Nolte MA, . Autologous cytomegalovirus-specific T cells as effector cells in immunotherapy of B cell chronic lymphocytic leukaemia. Br J Haematol 2004;126: 512–516.
   PubMed Web of Science ®Google Scholar
• Nishimura H, Nose M, Hiai H, . Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999;11: 141–151.
   PubMed Web of Science ®Google Scholar
• Kroner A, Mehling M, Hemmer B, . A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol 2005;58:50–57.
   PubMed Web of Science ®Google Scholar
• Hatachi S, Iwai Y, Kawano S, . CD4 + PD-1 + T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid. J Rheumatol 2003;30:1410–1419.
   PubMed Web of Science ®Google Scholar
• Nielsen C, Hansen D, Husby S, . Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes. Tissue Antigens 2003;62:492–497.
   PubMed Web of Science ®Google Scholar
• Dearden C. Disease-specific complications of chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program 2008:450–456.
   PubMedGoogle Scholar
• Akbar AN, Fletcher JM. Memory T cell homeostasis and senescence during aging. Curr Opin Immunol 2005;17:480–485 .
   PubMed Web of Science ®Google Scholar